209 related articles for article (PubMed ID: 25024138)
1. A peptide inhibitor of synuclein-γ reduces neovascularization of human endometriotic lesions.
Edwards AK; Ramesh S; Singh V; Tayade C
Mol Hum Reprod; 2014 Oct; 20(10):1002-8. PubMed ID: 25024138
[TBL] [Abstract][Full Text] [Related]
2. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
Virani S; Edwards AK; Thomas R; Childs T; Tayade C
Am J Reprod Immunol; 2013 Nov; 70(5):386-97. PubMed ID: 23650939
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model.
Nakamura DS; Edwards AK; Virani S; Thomas R; Tayade C
Am J Pathol; 2012 Aug; 181(2):570-82. PubMed ID: 22727957
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
5. Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions.
Feng D; Menger MD; Laschke MW
Fertil Steril; 2013 Nov; 100(5):1459-67. PubMed ID: 23993929
[TBL] [Abstract][Full Text] [Related]
6. Compatibility of a novel thrombospondin-1 analog with fertility and pregnancy in a xenograft mouse model of endometriosis.
Nakamura DS; Edwards AK; Ahn SH; Thomas R; Tayade C
PLoS One; 2015; 10(3):e0121545. PubMed ID: 25811892
[TBL] [Abstract][Full Text] [Related]
7. Animal models for anti-angiogenic therapy in endometriosis.
Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium derived factor inhibits the growth of human endometrial implants in nude mice and of ovarian endometriotic stromal cells in vitro.
Sun Y; Che X; Zhu L; Zhao M; Fu G; Huang X; Xu H; Hu F; Zhang X
PLoS One; 2012; 7(9):e45223. PubMed ID: 23028859
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.
Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356
[TBL] [Abstract][Full Text] [Related]
10. Targeting sphingosine kinase-1 with the low MW inhibitor SKI-5C suppresses the development of endometriotic lesions in mice.
Rudzitis-Auth J; Christoffel A; Menger MD; Laschke MW
Br J Pharmacol; 2021 Oct; 178(20):4104-4118. PubMed ID: 34185874
[TBL] [Abstract][Full Text] [Related]
11. Luminal epithelium in endometrial fragments affects their vascularization, growth and morphological development into endometriosis-like lesions in mice.
Feng D; Menger MD; Wang H; Laschke MW
Dis Model Mech; 2014 Feb; 7(2):225-32. PubMed ID: 24291760
[TBL] [Abstract][Full Text] [Related]
12. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.
Olivares CN; Alaniz LD; Menger MD; Barañao RI; Laschke MW; Meresman GF
PLoS One; 2016; 11(3):e0152302. PubMed ID: 27018976
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.
Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F
Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036
[TBL] [Abstract][Full Text] [Related]
15. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
[TBL] [Abstract][Full Text] [Related]
16. Crocin improves endometriosis by inhibiting cell proliferation and the release of inflammatory factors.
Liu Y; Qin X; Lu X
Biomed Pharmacother; 2018 Oct; 106():1678-1685. PubMed ID: 30119243
[TBL] [Abstract][Full Text] [Related]
17. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
18. Differences in growth and vascularization of ectopic menstrual and non-menstrual endometrial tissue in mouse models of endometriosis.
Nenicu A; Yordanova K; Gu Y; Menger MD; Laschke MW
Hum Reprod; 2021 Jul; 36(8):2202-2214. PubMed ID: 34109385
[TBL] [Abstract][Full Text] [Related]
19. ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model.
Wang Y; Lin M; Weng H; Wang X; Yang L; Liu F
Am J Obstet Gynecol; 2014 Jun; 210(6):531.e1-8. PubMed ID: 24495669
[TBL] [Abstract][Full Text] [Related]
20. The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model.
Quattrone F; Sanchez AM; Pannese M; Hemmerle T; Viganò P; Candiani M; Petraglia F; Neri D; Panina-Bordignon P
Reprod Sci; 2015 Sep; 22(9):1143-52. PubMed ID: 25850899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
